Montefiore Heart (@MonteHeart) header
Montefiore Heart (@MonteHeart) profile picture
Bronx, New York
Joined March 2020
Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)Photo by Montefiore Heart (@MonteHeart)
Congrats to our @MonteHeart clinician-scientists who ranked #1 in the @crfheart Scientific Excellence Top Ten for their significant contributions to interventional cardiovascular research in the Structural Category! #MonteProud #TCT2026 @EinsteinMed
8
12
930
Montefiore Heart retweeted
MonteHeart Lectures: Mauro Gitto (Humanitas, Milan) on bailout stenting in a DCB-based PCI strategy. Tuesday 29 Sep, 7:30am ET. einsteinmed.zoom.us/j/942854… @MonteHeart @MontefioreNYC @EinsteinMed @AndreaScotti21 @leoneppmd @lvjulien_md @andrea_mignatti @m_assafin
1
6
2
14
1,386
Montefiore Heart retweeted
⚠️ 1 in 5 patients undergoing M-TEER for primary MR has severe TR at baseline Their 2-year mortality: 29.6% (TR ≥Sev) vs 19.6% (TR ≤Mod) @CircIntv 🔗doi.org/10.1161/CIRCINTERVEN… 🧵 (1/4)
1
4
18
984
Montefiore Heart retweeted
Beyond stenosis: imaging phenotyping and risk stratification in nonobstructive coronary artery disease shorturl.at/fI2bu @pamelapina_s @AnnalisaFiltz @danilorenzatti @Ankurdee1 @JaideepBha35378 @Piotr_JSlomka @danielbermanmd @damini_dey @MonteHeart @MontefioreNYC @EinsteinMed
3
9
1
28
1,995
Montefiore Heart retweeted
South Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography Angiography. Outstanding work led by @DineshKalra and @virani_md just published in @JACCJournals jacc.org/doi/10.1016/j.jacas… @MontefioreNYC @MonteHeart @EinsteinMed
1
15
52
2,437
Montefiore Heart retweeted
Happy to share our editorial, "Another Win for Lifestyle Medicine: Cardiac Rehabilitation–Based Therapy for ANOCA," published in JACC: Cardiovascular Interventions alongside the important SAMCRO randomized trial. Despite the absence of obstructive coronary artery disease, patients with angina and no obstructive coronary arteries (ANOCA) often experience persistent symptoms, impaired quality of life, repeated testing, and uncertainty regarding their diagnosis. The challenge is no longer simply recognizing ANOCA but delivering effective, comprehensive treatment. Congratulations to the investigators for advancing the field with high-quality randomized evidence, and to my co-authors Chip Lavie and Fabian Sanchis-Gomar for the opportunity to collaborate on this editorial. Editorial: authors.elsevier.com/a/1nVvY… Original research: sciencedirect.com/science/ar… @CarlLavie31733 @MonteHeart @JACCJournals @ElsevierConnect
3
5
17
1,336
Montefiore Heart retweeted
Proud to share our review, now published in @ESC_Journals! PAD is an overlooked form of systemic atherosclerosis with a devastating prognosis. Time to bring it to the forefront of CV prevention. 🔗 academic.oup.com/eurheartj/a… @CardioMDPhD @DLBHATTMD @DrMichaelShapir @MarcBonaca
3
38
145
8,651
Montefiore Heart retweeted
In MESA, we evaluated cardiovascular event rates across CAC strata within 10-year PREVENT-ASCVD risk categories and statin eligibility groups defined by the 2026 ACC/AHA Multisociety Dyslipidemia Guideline. @JACCJournals @DrMichaelShapir jacc.org/doi/10.1016/j.jacc.…
9
20
3
72
10,505
Congrats to our @MonteHeart @CardioMDPhD Dr. Leandro Slipczuk, current Editor in Chief of @PCVDJournal which is now ranked #15 among cardiovascular medicine journals worldwide. We are #MonteProud! @EinsteinMed
1
6
16
862
Montefiore Heart retweeted
New TAVR, live at #NYValves2026 Live Case Session 10 (Mirus & DurAVR®) Thu June 25 | 9:10–10:10 AM Live Case Theater 🔹 Siegel TAVR (Mirus): Piedmont, Atlanta 🔹 DurAVR® (Anteris): Montefiore, NY Two live cases. Two new platforms. See you there! 🔗 nyvalvesconference.com/progr… nitter.cf/AndreaScotti21/status/…
3
8
801
Montefiore Heart retweeted
Proud to share that @PCVDJournal has achieved an Impact Factor of 10.6, ranking #15 among 237 cardiovascular journals worldwide. This remarkable milestone reflects the dedication of our authors, reviewers, editorial board members, and readers who continue to advance the field through high-quality scholarship and scientific rigor. We are especially grateful for the extraordinary leadership of the former EIC @CarlLavie31733, whose vision, commitment to excellence, and many years of service helped build the journal into the highly respected publication it is today. This achievement stands on the strong foundation he created. As we celebrate this accomplishment, we remain committed to publishing impactful reviews, top-quality original research and advancing knowledge that improves cardiovascular health worldwide. Thank you to everyone who has contributed to this success. The future of PCVD is bright. sciencedirect.com/journal/pr…
7
5
1
53
4,988
Montefiore Heart retweeted
Sharing our review of the top 10 takeaways for primary prevention from the 2026 Multisociety Dyslipidemia Guideline. Thank you to the great co-authors, including @AbdulMannan5465 and @virani_md pubmed.ncbi.nlm.nih.gov/4229…
13
47
3,435
Montefiore Heart retweeted
In a multicenter PET registry, patients with no evidence of flow-limiting CAD and discordantly low subendocardial myocardial flow reserve (MFR) had an increased risk of MACE than those with normal transmural & subendocardial MFR. ahajrnls.org/444SnyD
1
9
20
4,714
Montefiore Heart retweeted
🚨 HIV+ Donors for HIV+ Recipients: Win–Win? Want to learn more from the team that has performed the most HIV +/+ 🫀 transplants in the world? Join us at #MonteHeart on June 11 & 12! Registration➡️ eeds.com/live/867139 For info and full agenda ⤵️ @MonteHeart @azeemlatib
1
2
1
341
Montefiore Heart retweeted
💡TTVR - Jail or extract the lead? 🎯A novel device enters the field: TTVR w/ the Topaz system & pre-existing PPM lead - complete TR resolution and no lead compromise at 6 m ✨An innovative frame design in a challenging scenario! @azeemlatib #TTVR #treatTR
2
5
17
1,782
Montefiore Heart retweeted
New #JACCINT data from #TRIPLACE 📊 shows moderate/severe PVL in 6.1% after #TTVR 💉, linked to higher 1-year mortality ⚠️ and worse functional status. Larger RA size, device malposition, and valve morphology predict risk 🔍📈 jacc.org/doi/10.1016/j.jcin.…
1
14
36
4,733
Montefiore Heart retweeted
📢 Join us for the ASPC 2026 Virtual Imaging Symposium Multimodality Cardiovascular Imaging for Prevention: Essential Insights for Clinicians 🗓 April 25, 2026 ⏰ 8:00 AM – 12:55 PM EDT 💻 Half-day virtual event Discover how cutting-edge non-invasive imaging is transforming early detection, risk stratification, and management in preventive cardiology. Featured speakers include: @CardioMDPhD Leandro Slipczuk, MD, PhD, FASPC, @a_l_bailey Alison Bailey, MD, FASPC, @MichaelJBlaha Michael Blaha, MD, MPH, @khurramn1 Khurram Nasir, MD, MPH, MSc, FASPC, Parag Joshi, MD, MHS, @lesleejshaw Leslee Shaw, PhD, Matthew Budoff, MD, @DLBHATTMD Deepak L. Bhatt, MD, MPH, FASPC, Seamus Whelton, MD, MPH, Valentin Fuster, MD, PhD, @Borjaibanez1 Borja Ibanez, MD, PhD, Beatriz López-Melgar, MD, PhD, Harold Bays, MD, FASPC, Salvatore Carbone, PhD, RDN, @DonnaRyanMD Donna H. Ryan, MD Unrestricted educational support for the program is provided by industry partners @Heartflow and @Cleerlyhealth. Don’t miss this opportunity to gain practical, high-impact insights from leaders shaping the future of cardiovascular prevention. 🔗 Learn more & register: aspconline.org/virtual-imagi… #PreventiveCardiology #CardioImaging #ASPC #MedEd #Cardiology @AJPcardio
15
3
21
9,268
Montefiore Heart retweeted
Keeping the momentum going with the @ASPCardio 2026 Virtual Imaging Symposium! Are you registered? @a_l_bailey @CardioMDPhD @MichaelJBlaha @khurramn1 @DLBHATTMD @BudoffMd @DrPJoshi @seamuswhelton @Borjaibanez1 @DonnaRyanMD & many more incredible faculty! @AJPCardio
📢 Join us for the ASPC 2026 Virtual Imaging Symposium Multimodality Cardiovascular Imaging for Prevention: Essential Insights for Clinicians 🗓 April 25, 2026 ⏰ 8:00 AM – 12:55 PM EDT 💻 Half-day virtual event Discover how cutting-edge non-invasive imaging is transforming early detection, risk stratification, and management in preventive cardiology. Featured speakers include: @CardioMDPhD Leandro Slipczuk, MD, PhD, FASPC, @a_l_bailey Alison Bailey, MD, FASPC, @MichaelJBlaha Michael Blaha, MD, MPH, @khurramn1 Khurram Nasir, MD, MPH, MSc, FASPC, Parag Joshi, MD, MHS, @lesleejshaw Leslee Shaw, PhD, Matthew Budoff, MD, @DLBHATTMD Deepak L. Bhatt, MD, MPH, FASPC, Seamus Whelton, MD, MPH, Valentin Fuster, MD, PhD, @Borjaibanez1 Borja Ibanez, MD, PhD, Beatriz López-Melgar, MD, PhD, Harold Bays, MD, FASPC, Salvatore Carbone, PhD, RDN, @DonnaRyanMD Donna H. Ryan, MD Unrestricted educational support for the program is provided by industry partners @Heartflow and @Cleerlyhealth. Don’t miss this opportunity to gain practical, high-impact insights from leaders shaping the future of cardiovascular prevention. 🔗 Learn more & register: aspconline.org/virtual-imagi… #PreventiveCardiology #CardioImaging #ASPC #MedEd #Cardiology @AJPcardio
1
11
21
2,313
Montefiore Heart retweeted
Grateful to @TCTMD_Yael and @TCTMD for highlighting our work, led by @CardioMDPhD ! @MontefioreNYC @MonteHeart
Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD dlvr.it/TRgrBW
3
18
1,357
Montefiore Heart retweeted
⚠️ Are we underestimating paravalvular leak after TTVR? In TRIPLACE, ≥Mod PVL occurred in 6.1% and was associated w/ 🔴39.7% 1-year mortality 🔴2.6X higher risk of death 🔴Less symptomatic improvement despite successful TTVR 🔗doi.org/10.1016/j.jcin.2026.… @azeemlatib Rishi Puri
1
12
1
37
3,436